CV

curative ventures

North America, Texas, United States, Dallas

Description

Curative Ventures is a capital and talent partner to category-defining biotech companies.

Investor Profile

curative ventures has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (75%)
  • Series E (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Oncology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does curative ventures frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 2
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 2
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2

Which angels does curative ventures often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by curative ventures?

ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series BApr 1, 2020
Amount Raised: $125,000,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series EFeb 20, 2019
Amount Raised: $150,000,000
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series BJun 20, 2018
Amount Raised: $75,000,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series BMar 21, 2018
Amount Raised: $125,000,000